Form D · Biotechnology
EXACT SCIENCES CORP
Marlborough, MA · CIK 0001124140
Offering snapshot reported Jun 16, 2009 · SEC filing
- Reported sold
- $8.2M Offering amount: $8.2M
- Investors reported
- 11 Form D · investor count
- Minimum accepted
- $200K Reported outside-investor minimum
- First sale
- Jun 11, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 16, 2009 | Initial | $8,200,000 | No comparison | 11 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-46081
Source: Form D, filed Jun 16, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Maneesh Arora | Executive |
| James Connelly | Director |
| Kevin T Conroy | Director, Executive |
| Sally W Crawford | Director |
| Connie Mack Iii | Director |
| Katherine Napier | Director |
| Michael Singer | Director |
| Lance Willsey, Md | Director |
| Patrick J Zenner | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
100 Campus Drive
Marlborough, MA, 01752
Marlborough, MA, 01752